Get started
Author

Tamaki Fukuyama

Observed name: T. Fukuyama
ORCID: 0000-0002-7017-8416
Observed ORCID: 0000-0002-7017-8416
OpenAlex ID: A5060338703
A prospective, phase II, open-label study (JO22903) of first-line erlotinib in Japanese patients with epidermal growth factor receptor (EGFR) mutation-positive advanced non-small-cell lung cancer (NSCLC)
2013 · Koichi Goto, Makoto Nishio, et al. · Lung Cancer · 98
PDF
Association of green tea consumption with mortality due to all causes and major causes of death in a Japanese population: the Japan Public Health Center-based Prospective Study (JPHC Study)
2015 · Eiko Saito, Manami Inoue, et al. · Annals of Epidemiology · 87
Dietary intake of saturated fatty acids and incident stroke and coronary heart disease in Japanese communities: the JPHC Study
2013 · K. Yamagishi, H. Iso, et al. · European Heart Journal · 81
PDF
Prospective and clinical validation of ALK immunohistochemistry: results from the phase I/II study of alectinib for ALK-positive lung cancer (AF-001JP study)
2015 · K. Takeuchi, Y. Togashi, et al. · Annals of Oncology · 62
PDF
Effects of caloric restriction on gene expression in the arcuate nucleus
2002 · I Shimokawa, Tamaki Fukuyama, et al. · Neurobiology of Aging · 33
The Association of Tumor Immune Microenvironment of the Primary Lesion with Time to Metastasis in Patients with Renal Cell Carcinoma: A Retrospective Analysis
2022 · Kazutoshi Fujita, Go Kimura, et al. · Cancers · 8
PDF
Prognostic value of PD-L1 expression in recurrent renal cell carcinoma after nephrectomy: a secondary analysis of the ARCHERY study
2022 · Satoshi Tamada, Masahiro Nozawa, et al. · International Journal of Clinical Oncology · 5
PDF
Prognostic value of immune phenotype and PD-L1 status in recurrent or metastatic renal cell carcinoma: an exploratory analysis of the ARCHERY study
2022 · Toyonori Tsuzuki, Chisato Ohe, et al. · Pathology · 5
PDF
Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma
2021 · Motohide Uemura, Noboru Nakaigawa, et al. · International Journal of Clinical Oncology · 5
PDF
Comprehensive investigation of clinicopathological and immunological features to determine prognostic impact in metastatic renal cell carcinoma: The JEWEL study
2023 · Kojiro Ohba, Keisuke Monji, et al. · International Journal of Urology · 3
PDF
Genetic drivers of severe skin toxicity with immune checkpoint inhibitors (ICIs) in Asian patients.
2024 · Kohei Yoshimine, Hiroki Goto, et al. · Journal of Clinical Oncology · 1
PDF
EP.06.12 Kita-Kyusyu Lung Cancer Antigen-1 Positive Is Associated With Pathological High-Grade in Lung Adenocarcinoma
2025 · Y. Kondo, T. Fukuyama, et al. · Journal of Thoracic Oncology
Correction to: Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma
2021 · Motohide Uemura, Noboru Nakaigawa, et al. · International Journal of Clinical Oncology
PDF
729P Prognostic value of PD-L1 status in the primary lesion as a risk factor for developing metastatic disease in localized renal cell carcinoma: A subgroup analysis of the ARCHERY study
2020 · M. Nozawa, S. Tamada, et al. · Annals of Oncology
PDF
725P Prognostic values of PD-L1 expression and CD8 infiltration phenotype in metastatic and recurrent renal cell carcinoma: An exploratory analysis of the ARCHERY study
2020 · T. Tsuzuki, C. Ohe, et al. · Annals of Oncology
PDF
Abstract LB-153: Prognostic value of PD-L1 expression on tumor-infiltrating immune cells in renal cell carcinoma (ARCHERY study)
2020 · Hirotsugu Uemura, Motohide Uemura, et al. · Cancer Research
Lba02-02 Prognostic Value of Pd-l1 Expression on Tumor-infiltrating Immune Cells in Renal Cell Carcinoma (archery Study)
2020 · Katsunori Tatsugami*, Motohide Uemura, et al. · The Journal of Urology
PD-012 Establishment of lung cancer cell lines and identification of tumor antigens recognized by CTL
2005 · T. Hanagiri, M. Sugaya, et al. · Lung Cancer
O-022 Identification of antigens in lung cancer by using IgG derived from tumor-infiltrating B lymphocytes
2005 · M. Mizukami, T. Hanagiri, et al. · Lung Cancer
Works count: 19
Citation count: 388
H-index: 6
I10-index: 5
Year
Topic
Type